Treatment outcomes of patients with G3 neuroendocrine neoplasms Data from the German NET Registry

被引：0
|
作者：
Luecke, S. [1 ]
Fottner, C. [2 ]
Lahner, H. [3 ]
Jann, H. [4 ]
Zolnowski, D. [5 ]
Grabowski, P. [6 ]
Cremer, B. [7 ]
Quietzsch, D.
Maasberg, S. [8 ]
Pape, U. F. [8 ]
Gress, T. M. [1 ]
Rinke, A. [1 ]
机构：
[1] Uniklinikum Giessen & Marburg, Gastroenterol, Marburg, Germany
[2] Univ Hosp Mainz, Endocrinol, Mainz, Germany
[3] Univ Hosp Essen, Endocrinol, Essen, Germany
[4] Univ Hosp Charite, Gastroenterol, Berlin, Germany
[5] Klinikum Chemnitz, Oncol, Chemnitz, Germany
[6] Hosp Havelhohe, Oncol, Berlin, Germany
[7] Univ Hosp Cologne, Oncol, Cologne, Germany
[8] Asklepios Klin St Georg, Gastroenterol, Hamburg, Germany
来源：
JOURNAL OF NEUROENDOCRINOLOGY | 2021年 / 33卷
关键词：
nen g3; nec; net; ki67; prognosis; chemotherapy;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
D30
引用
收藏
页码：72 / 72
页数：1
相关论文
共 50 条
  • [31] Safety and efficacy of everolimus (EVE) as second-line treatment in neuroendocrine neoplasms G3 (NEN G3) - an AIO phase II study (EVINEC)
    Pavel, Marianne
    Kloeppel, Guenter
    von Weikersthal, Ludwig Fischer
    Hoersch, Dieter
    Mayer, Karin
    Schrader, Joerg
    Augustin, Marinela
    Venerito, Marino
    Krause, Katrin
    Apostolidis, Leonidas
    ONCOLOGY RESEARCH AND TREATMENT, 2024, 47 : 236 - 236
  • [32] Characteristics, Treatments and Inflammatory Biomarkers in Patients (pts) with G3 Gastroenteropancreatic (GEP) Neuroendocrine Neoplasms (NENs)
    Cameselle-Garcia, S.
    Sardo, E.
    Landolfi, S.
    Merino-Casabiel, X.
    Sanchez, J. L.
    Balsells, J.
    Pando, E.
    Blanco, L.
    Diez, M.
    Acosta, D.
    Capdevila, J.
    Hernando, J.
    NEUROENDOCRINOLOGY, 2020, 110 : 64 - 64
  • [33] Safety and efficacy of everolimus (EVE) as second-line treatment in neuroendocrine neoplasms G3 (NEN G3): An AIO phase II study (EVINEC)
    Pavel, M. E.
    von Weikersthal, L. Fischer
    Kloeppel, G.
    Krause, K.
    Apostolidis, L.
    ANNALS OF ONCOLOGY, 2023, 34 : S702 - S702
  • [34] Characteristics and Treatments of Patients with G3 Gastroenteropancreatic Neuroendocrine Tumors (G3-NET) and Neuroendocrine Carcinoma (NEC): An European Multicenter Retrospective Study
    Heetfeld, M.
    Rinke, A.
    Borbath, I
    Crespo, G.
    Olsen, I. H.
    Chougnet, C.
    Pavel, M.
    O'Toole, D.
    Walter, T.
    NEUROENDOCRINOLOGY, 2014, 99 (3-4) : 235 - 236
  • [35] Invited Editorial on Surgical Treatment of G3 Gastroenteropancreatic Neuroendocrine Neoplasms: Pay Close Attention to the Pathology Report
    Pommier, Rodney F.
    ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (01) : 12 - 14
  • [36] Sunitinib shrinks NET-G3 pancreatic neuroendocrine neoplasms
    Mizuno, Yuki
    Kudo, Atsushi
    Akashi, Takumi
    Akahoshi, Keiichi
    Ogura, Toshiro
    Ogawa, Kosuke
    Ono, Hiroaki
    Mitsunori, Yusuke
    Ban, Daisuke
    Tanaka, Shinji
    Tateishi, Ukihide
    Tanabe, Minoru
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2018, 144 (06) : 1155 - 1163
  • [37] Invited Editorial on Surgical Treatment of G3 Gastroenteropancreatic Neuroendocrine Neoplasms: Pay Close Attention to the Pathology Report
    Rodney F. Pommier
    Annals of Surgical Oncology, 2023, 30 : 12 - 14
  • [38] Sunitinib shrinks NET-G3 pancreatic neuroendocrine neoplasms
    Yuki Mizuno
    Atsushi Kudo
    Takumi Akashi
    Keiichi Akahoshi
    Toshiro Ogura
    Kosuke Ogawa
    Hiroaki Ono
    Yusuke Mitsunori
    Daisuke Ban
    Shinji Tanaka
    Ukihide Tateishi
    Minoru Tanabe
    Journal of Cancer Research and Clinical Oncology, 2018, 144 : 1155 - 1163
  • [39] Clinical Outcome of Everolimus Treatment of Advanced Neuroendocrine Neoplasms: 'Real-Life' Data from the German NET-Register
    Pape, U. F.
    Bacher, M.
    Fottner, C.
    Lahner, H.
    Begum, N.
    Quietzsch, D.
    Skrobek-Engel, G.
    Pavel, M.
    Rinke, A.
    Maasberg, S.
    NEUROENDOCRINOLOGY, 2015, 102 (1-2) : 132 - 132
  • [40] Results of Sunitinib Treatment of Advanced Neuroendocrine Neoplasms: 'Real-Life' Outcome Data from the German NET-Register
    Bacher, M.
    Maasberg, S.
    Fottner, C.
    Begum, N.
    Quietzsch, D.
    Skrobek-Engel, G.
    Pavel, M.
    Rinke, A.
    Lahner, H.
    Pape, U. F.
    NEUROENDOCRINOLOGY, 2015, 102 (1-2) : 127 - 127
12345